Beta-blocking drugs increase responsiveness to prostacyclin in hypertensive patients

Lancet. 1982 Aug 21;2(8295):444. doi: 10.1016/s0140-6736(82)90475-5.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / metabolism*
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Cyclic AMP / blood
  • Epoprostenol / physiology*
  • Female
  • Humans
  • Hypertension / drug therapy
  • Hypertension / physiopathology*
  • Male
  • Middle Aged
  • Prostaglandins / physiology*

Substances

  • Adrenergic beta-Antagonists
  • Prostaglandins
  • Epoprostenol
  • Cyclic AMP